Virax Biolabs Group Limited (NASDAQ: VRAX) announced it completed patient recruitment for its United Kingdom clinical study evaluating the ViraxImmune ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE